PMID- 18005322 OWN - NLM STAT- MEDLINE DCOM- 20080328 LR - 20080130 IS - 0041-1132 (Print) IS - 0041-1132 (Linking) VI - 48 IP - 2 DP - 2008 Feb TI - Human immunodeficiency virus-1 infection correlates strongly with herpes simplex virus-2 (genital herpes) seropositivity in South African and United States blood donations. PG - 295-303 AB - BACKGROUND: In South Africa, human immunodeficiency virus-1 (HIV-1) infection correlates with herpes simplex virus-2 (HSV-2; genital herpes) seropositivity in genitourinary disease clinic attendees. HSV-2 infection may be a marker for risk behavior and/or directly facilitate HIV-1 transmission. The rate of HSV-2 infection in HIV-infected South African and US blood donations was assessed, and whether the infections were correlated in donors screened and found negative for high-risk behavior by predonation interview was questioned. STUDY DESIGN AND METHODS: A total of 625 South African and 393 US HIV-1-infected repository samples previously characterized for longstanding or recent HIV-1 infection were tested with two commercially available HSV-2-specific assays. The prevalence of HSV-2 antibodies in South Africa was further assessed in 106 HIV-1-infected and 106 HIV-1-negative donors matched for sex, race, and donation history, as well as 200 random HIV-1-negative donors. RESULTS: A total of 52.2 percent of US and 69.3 percent of South African HIV-1-infected donations were HSV-2-seropositive. Age, race, and sex were independent risk factors for HSV-2 antibody prevalence in HIV-1-infected South African donors, who were more likely to be HSV-2 antibody-reactive than random HIV-1-negative donors (72.6% vs. 8.5%: odds ratio [OR], 28.6; 95% confidence interval [CI], 14.5-55) or matched donors (71.6% vs. 19.6%: OR, 10.3; 95% CI, 5.4-19.8). HIV-1 infection and HSV-2 seropositivity correlated in white and black populations when analyzed by age group. CONCLUSIONS: HIV-1 infection correlates strongly with HSV-2 seropositivity in US and South African blood donors. Our data describe the characteristics of HSV-2 antibody testing as a surrogate marker for HIV-1 infection and support a facilitating role for HSV-2 infection in HIV-1 transmission. FAU - Benjamin, Richard J AU - Benjamin RJ AD - Biomedical Services, Medical Office, American Red Cross, Washington, DC 20006, USA. BenjaminR@usa.redcross.org FAU - Busch, Michael P AU - Busch MP FAU - Fang, Chyang T AU - Fang CT FAU - Notari, Edward P AU - Notari EP FAU - Puren, Adrian AU - Puren A FAU - Schoub, Barry D AU - Schoub BD FAU - Tobler, Leslie H AU - Tobler LH FAU - Hogrefe, Wayne AU - Hogrefe W FAU - du P Heyns, Anthon AU - du P Heyns A FAU - Stramer, Susan L AU - Stramer SL FAU - Crookes, Robert L AU - Crookes RL LA - eng PT - Journal Article DEP - 20071113 PL - United States TA - Transfusion JT - Transfusion JID - 0417360 RN - 0 (Antibodies, Viral) SB - IM MH - Adolescent MH - Adult MH - Antibodies, Viral/immunology MH - *Blood Donors MH - Female MH - HIV Infections/*blood/*virology MH - HIV-1/*physiology MH - Herpes Genitalis/*blood/*virology MH - *Herpesvirus 2, Human/immunology MH - Humans MH - Male MH - South Africa MH - Time Factors EDAT- 2007/11/17 09:00 MHDA- 2008/03/29 09:00 CRDT- 2007/11/17 09:00 PHST- 2007/11/17 09:00 [pubmed] PHST- 2008/03/29 09:00 [medline] PHST- 2007/11/17 09:00 [entrez] AID - TRF01523 [pii] AID - 10.1111/j.1537-2995.2007.01523.x [doi] PST - ppublish SO - Transfusion. 2008 Feb;48(2):295-303. doi: 10.1111/j.1537-2995.2007.01523.x. Epub 2007 Nov 13.